Literature DB >> 32448726

New-onset heart failure after acute coronary syndrome in patients without heart failure or left ventricular dysfunction.

Alberto Cordero1, Moisés Rodríguez-Mañero2, Vicente Bertomeu-González3, José M García-Acuña2, Aurora Baluja4, Rosa Agra-Bermejo2, Belén Álvarez-Álvarez2, Belén Cid2, Pilar Zuazola5, José R González-Juanatey2.   

Abstract

INTRODUCTION AND
OBJECTIVES: Coronary heart disease is the leading cause of heart failure (HF). The aim of this study was to assess the risk of readmission for HF in patients with acute coronary syndrome without previous HF or left ventricular dysfunction.
METHODS: Prospective study of consecutive patients admitted for acute coronary syndrome in 2 institutions. Risk factors for HF were analyzed by competing risk regression, taking all-cause mortality as a competing event.
RESULTS: We included 5962 patients and 567 (9.5%) experienced at least 1 hospital readmission for acute HF. Median follow-up was 63 months and median time to HF readmission was 27.1 months. The cumulative incidence of HF was higher than mortality in the first 7 years after hospital discharge. A higher risk of HF readmission was associated with age, diabetes, previous coronary heart disease, GRACE score> 140, peripheral arterial disease, renal dysfunction, hypertension and atrial fibrillation; a lower risk was associated with optimal medical treatment. The incidence of HF in the first year of follow-up was 2.73% and no protective variables were found. A simple HF risk score predicted HF readmissions risk.
CONCLUSIONS: One out of 10 patients discharged after an acute coronary syndrome without previous HF or left ventricular dysfunction had new-onset HF and the risk was higher than the risk of mortality. A simple clinical score can estimate individual risk of HF readmission even in patients without previous HF or left ventricular dysfunction.
Copyright © 2020 Sociedad Española de Cardiología. Published by Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Acute coronary syndrome; Beta-blockers; Bloqueadores beta; Heart failure; Insuficiencia cardiaca; Revascularización; Revascularization; Síndrome coronario agudo

Year:  2020        PMID: 32448726     DOI: 10.1016/j.rec.2020.03.011

Source DB:  PubMed          Journal:  Rev Esp Cardiol (Engl Ed)        ISSN: 1885-5857


  2 in total

1.  Validation and Psychometric Properties of the Minnesota Living With Heart Failure Questionnaire in Individuals With Coronary Artery Disease in Lithuania.

Authors:  Julija Gecaite-Stonciene; Julius Burkauskas; Adomas Bunevicius; Vesta Steibliene; Jurate Macijauskiene; Julija Brozaitiene; Narseta Mickuviene; Nijole Kazukauskiene
Journal:  Front Psychol       Date:  2022-02-04

2.  Prevalence, Characteristics, Management and Outcomes of Patients with Heart Failure with Preserved, Mildly Reduced, and Reduced Ejection Fraction in Spain.

Authors:  Carlos Escobar; Beatriz Palacios; Luis Varela; Martín Gutiérrez; Mai Duong; Hungta Chen; Nahila Justo; Javier Cid-Ruzafa; Ignacio Hernández; Phillip R Hunt; Juan F Delgado
Journal:  J Clin Med       Date:  2022-09-02       Impact factor: 4.964

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.